Company
Hatteras Venture Partners
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| 410 Medical, Inc. | 2026-07-14 | 2026-07-14 | |
| Ladder Health | Seed | 2026-06-23 | |
| iRiva Medical | Financing | 2025-11-11 | |
| Boomerang Medical | Series B | 2025-09-04 | |
| Sensorium Therapeutics | Series A | 2025-08-29 | |
| GeneCentric Therapeutics | Series C | 2025-06-18 | Lead |
| Atsena Therapeutics | Series C | 2025-04-04 | |
| BEKhealth | Undisclosed | 2025-02-14 | Lead |
| Endogenex | Series C Financing | 2024-06-25 | |
| AtaCor Medical | Series C Funding | 2024-04-25 | Lead |
| iVEAcare | Series A Funding | 2024-04-22 | Lead |
| Elligo Health Research | Investment | 2023-10-02 | |
| Ten63 Therapeutics | Series A Financing | 2023-06-15 | Lead |
| Aer Therapeutics | Series A Financing | 2023-04-14 | |
| Mercy BioAnalytics | Series A Funding | 2023-04-03 | |
| Cardiosense | Series A | 2022-12-09 | Lead |
| RapidPulse, Inc. | Funding round | 2022-09-14 |